Market Notice
The security KalVista Pharmaceuticals Inc. Registered Shares DL -,001 with ISIN US4834971032 is currently suspended from trading. Please note that existing orders in this security have been cancelled. Orders can be placed again once trading is resumed.
KalVista Pharmaceuticals Inc. Registered Shares DL -,001
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
86.72%
Market Cap
-
P/E Ratio (e)
0.00
Dividend Yield (e)
0.00 %
Earnings per Share (e)
-0.96 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 23.34 G | 0 Units |
| PRICE DETERMINATION TIME | 06/10/2026 / 09:57:15 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 23.34 | 22.75 |
| PREV. DAY'S PRICE | 23.34 | (06/09) |
| CHANGE DAY BEFORE | +0.00 | 0.00 % |
| 52 WEEK HIGH / LOW | 23.37 (06/05) | 9.05 (10/30) |
Key Figures (in EUR)
| 2027e | 2026e | 2025e | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 0.57 | -0.96 | -1.73 | - | - |
| DIVIDENDS PER SHARE | 0.00 | 0.00 | - | - | - |
| DIVIDEND YIELD IN % | - | - | - | - | - |
| DIVIDEND GROWTH IN % | - | - | - | - | - |
| PRICE - EARNINGS RATIO | 41.15 | - | - | - | - |
| PRICE - BOOK RATIO | - | - | - | - | - |
| PRICE - SALES RATIO | - | - | - | - | - |
| PRICE - CASH FLOW RATIO | - | - | - | - | - |
Master Data
| WKN | A2DG49 |
| ISIN | US4834971032 |
| SYMBOL | 4XC1 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | KALVISTA PHARMA. DL-,001 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 08:00:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 0.69 % | 3.09 % | 50.58 % | 70.36 % | 86.72 % | 155.08 % | 0.60 % | 83.78 % |
| HIGH | 23.37 | 23.37 | 23.37 | 23.37 | 23.37 | 23.37 | 25.00 | 23.37 |
| LOW | 22.48 | 22.12 | 12.90 | 12.00 | 9.05 | 6.75 | 4.22 | 12.00 |
Dividend
per share
KALVISTA PHARMA. DL-,001 does not deliver dividend information
Company profile
No company profile available.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.